CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

PRESS RELEASEAB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE ...

Join the mega job fair in Kallakurichi on January 10, featuring over 150 companies and opportunities for all education levels.

In the shadow of the Mission Mountains, Pinehaven Christian Children's Ranch sits where cell service fades and the landscape ...

AL-S Pharma AG, a Swiss-based, single-asset clinical-stage biopharmaceutical company founded and co-owned by Neurimmune and TVM Capital Life Science, is developing AP-101 for Amyotrophic Lateral ...

Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register ...

Lifting heavy—at any age—is backed by science. Take an investigation aptly named the LIFTMOR study: When postmenopausal women ...

Mr. Celebi's appointment comes as Egle enhances its clinical development focus on autoimmune diseases, where recent validation of the IL-2 mechanism has created a significant opportunity for ...

Pulcini helped Vietnam war refugees Shortly after graduating from LaVerne College in 1963, June and her husband Ron Pulcini ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

Cell division is an essential process for all life on Earth, yet the exact mechanisms by which cells divide during early ...

InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the ...